{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining FDA's generic drug and biosimilar user fee programs :
hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Examining FDA's Generic Drug And Biosimilar User Fee Programs : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Fifteenth Congress, First Session, March 2, 2017.
United States.
U.S. Government Publishing Office,
2018.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Examining FDA's Prescription Drug User Fee program :
hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Examining FDA's Prescription Drug User Fee Program : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Fifteenth Congress, First Session, March 22, 2017.
United States.
U.S. Government Publishing Office,
2018.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Generic drug user fee amendments :
accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining generic drug user fee amendments, focusing on accelerating patient access to generic drugs, January 28, 2016.
Generic Drug User Fee Amendments : Accelerating Patient Access To Generic Drugs : Hearing Of The Committee On Health, Education, Labor, And Pensions, United States Senate, One Hundred Fourteenth Congress, Second Session On Examining Generic Drug User Fee Amendments, Focusing On Accelerating Patient Access To Generic Drugs, January 28, 2016.
United States.
U.S. Government Publishing Office,
2018.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Generic drug user fee amendments (GDUFA) :
background and reauthorization
Generic Drug User Fee Amendments (GDUFA) : Background And Reauthorization / Agata Bodie.
Bodie, Agata,
Congressional Research Service,
[2021]
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Generic pharmaceuticals :
marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Generic Pharmaceuticals : Marketplace Access And Consumer Issues : Hearing Before The Committee On Commerce, Science, And Transportation, United States Senate, One Hundred Seventh Congress, Second Session, April 23, 2002.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2004.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Generic pharmaceuticals :
marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Generic Pharmaceuticals : Marketplace Access And Consumer Issues : Hearing Before The Committee On Commerce, Science, And Transportation, United States Senate, One Hundred Seventh Congress, Second Session, April 23, 2002.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2004.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Paying off generics to prevent competition with brand name drugs :
should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Paying Off Generics To Prevent Competition With Brand Name Drugs : Should It Be Prohibited? : Hearing Before The Committee On The Judiciary, United States Senate, One Hundred Tenth Congress, First Session, January 17, 2007.
United States.
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2007.
{{indexedTitle}} appears in the content of this record.
{{title}} can only be used in the library.
A copy of {{title}} has been set aside for library use only.
Paying off generics to prevent competition with brand name drugs :
should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Paying Off Generics To Prevent Competition With Brand Name Drugs : Should It Be Prohibited? : Hearing Before The Committee On The Judiciary, United States Senate, One Hundred Tenth Congress, First Session, January 17, 2007.
United States.
U.S. Government Printing Office,
2007.
